Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$1.35
-1.5%
$1.40
$1.14
$73.75
$225K-0.471.80 million shs103,061 shs
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
$1.09
-4.4%
$1.57
$1.03
$16.18
$172K-0.8408,682 shs86,907 shs
NEPTF
Neptune Wellness Solutions
$0.02
-49.8%
$0.02
$0.00
$0.12
$68K-2.622,503 shs9,937 shs
Trevena, Inc. stock logo
TRVN
Trevena
$0.28
-1.8%
$0.83
$0.25
$7.85
$264K0.411,996 shs821 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bon Natural Life Limited stock logo
BON
Bon Natural Life
+5.38%+5.38%-2.84%-9.87%-97.31%
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
-8.06%-8.06%-29.63%-42.13%+113,999,900.00%
NEPTF
Neptune Wellness Solutions
0.00%+113.57%+113.57%+498.00%+2,989,900.00%
Trevena, Inc. stock logo
TRVN
Trevena
-1.79%+5.77%-69.78%-74.77%-92.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/AN/AN/AN/A
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
0.0064 of 5 stars
0.01.00.00.00.00.00.0
Trevena, Inc. stock logo
TRVN
Trevena
1.1489 of 5 stars
3.02.00.00.00.60.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.00
N/AN/AN/A
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
0.00
N/AN/AN/A
NEPTF
Neptune Wellness Solutions
2.00
HoldN/AN/A
Trevena, Inc. stock logo
TRVN
Trevena
2.00
Hold$5.001,718.18% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$23.84M0.01$1.73 per share0.78$37.78 per share0.04
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
$43.38M0.00N/AN/A($19.40) per share-0.06
NEPTF
Neptune Wellness Solutions
$52.62M0.00N/AN/A($91.90) per share0.00
Trevena, Inc. stock logo
TRVN
Trevena
$443K0.60N/AN/A($11.07) per share-0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$400KN/A0.00N/AN/AN/AN/AN/A
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
-$2.56MN/A0.00N/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
-$60.46M-$106.72N/AN/AN/AN/AN/AN/A
Trevena, Inc. stock logo
TRVN
Trevena
-$40.29M-$47.04N/AN/AN/AN/AN/A-119.55%11/5/2025 (Estimated)

Latest NEPTF, TRVN, BON, and CAPS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/15/2025Q2 2025
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
N/A-$0.13N/A-$0.13N/A$12.85 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/A
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
N/AN/AN/AN/AN/A
NEPTF
Neptune Wellness Solutions
N/AN/AN/AN/AN/A
Trevena, Inc. stock logo
TRVN
Trevena
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.02
2.42
2.32
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
0.28
1.14
0.47
NEPTF
Neptune Wellness Solutions
N/AN/AN/A
Trevena, Inc. stock logo
TRVN
Trevena
N/A
2.42
2.42

Institutional Ownership

CompanyInstitutional Ownership
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.57%
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
2.55%
NEPTF
Neptune Wellness Solutions
11.72%
Trevena, Inc. stock logo
TRVN
Trevena
13.56%

Insider Ownership

CompanyInsider Ownership
Bon Natural Life Limited stock logo
BON
Bon Natural Life
26.48%
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
42.80%
NEPTF
Neptune Wellness Solutions
5.10%
Trevena, Inc. stock logo
TRVN
Trevena
2.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bon Natural Life Limited stock logo
BON
Bon Natural Life
100167,000863,000Not Optionable
Capstone Therapeutics Corp. stock logo
CAPS
Capstone Therapeutics
38158,00090,000N/A
NEPTF
Neptune Wellness Solutions
1304.53 million4.30 millionN/A
Trevena, Inc. stock logo
TRVN
Trevena
40959,000841,000Optionable

Recent News About These Companies

Trevena, Inc. (TRVN) - Yahoo Finance
JMP Securities downgrades Trevena (TRVN) to a Hold
Lyme Regis town councillor John Trevena stand down
Trevena appoints new financial chief
Trevena Appoints Katrine Sutton as New CFO
HC Wainwright & Co. Downgrades Trevena (TRVN)
Why Trevena (TRVN) Stock Is Down 43% Today
Trevena, Inc. Faces Delisting from Nasdaq
Trevena Announces Receipt of Nasdaq Delisting Notification
Learn to Evaluate (TRVN) using the Charts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bon Natural Life stock logo

Bon Natural Life NYSE:BON

$1.35 -0.02 (-1.46%)
Closing price 04:00 PM Eastern
Extended Trading
$1.36 +0.01 (+0.74%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.

Capstone Therapeutics stock logo

Capstone Therapeutics NASDAQ:CAPS

$1.09 -0.05 (-4.39%)
As of 04:00 PM Eastern

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

Neptune Wellness Solutions OTC:NEPTF

$0.02 -0.01 (-49.83%)
As of 09:59 AM Eastern

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Trevena stock logo

Trevena NASDAQ:TRVN

$0.28 -0.01 (-1.79%)
As of 08/18/2025 10:49 AM Eastern

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.